BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar D, LeCorchick S, Gupta G. Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants. Front Med (Lausanne) 2017;4:60. [PMID: 28580358 DOI: 10.3389/fmed.2017.00060] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Cheng CH, Lee CF, Oh BC, Furtmüller GJ, Patel CH, Brandacher G, Powell JD. Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression. Front Immunol 2020;11:572. [PMID: 32328063 DOI: 10.3389/fimmu.2020.00572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Afzali S, Salehi S, Shahi A, Amirzargar A. B cell modulation strategies in the improvement of transplantation outcomes. Mol Immunol 2020;125:140-50. [PMID: 32682148 DOI: 10.1016/j.molimm.2020.06.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kumar D, Yakubu I, Cooke RH, Halloran PF, Gupta G. Belatacept rescue for delayed kidney allograft function in a patient with previous combined heart-liver transplant. Am J Transplant 2018;18:2613-4. [PMID: 29981184 DOI: 10.1111/ajt.15003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Jin L, Lim SW, Jin J, Luo K, Ko EJ, Chung BH, Lin HL, Yang CW. Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats. Transplantation 2018;102:e137-46. [PMID: 29319618 DOI: 10.1097/TP.0000000000002048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Spagnuolo V, Uberti-Foppa C, Castagna A. Pharmacotherapeutic management of HIV in transplant patients. Expert Opin Pharmacother 2019;20:1235-50. [PMID: 31081726 DOI: 10.1080/14656566.2019.1612364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Bellini MI, Paoletti F, Herbert PE. Obesity and bariatric intervention in patients with chronic renal disease. J Int Med Res 2019;47:2326-41. [PMID: 31006298 DOI: 10.1177/0300060519843755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Cristea O, Karadkhele G, Kitchens WH, Vasanth P, Larsen CP, Badell IR. Belatacept Conversion in Kidney After Liver Transplantation. Transplant Direct 2021;7:e780. [PMID: 34712780 DOI: 10.1097/TXD.0000000000001229] [Reference Citation Analysis]
8 Cortés-Hernández A, Alvarez-Salazar E, Arteaga-Cruz S, Alberu-Gómez J, Soldevila G. Ex vivo expansion of regulatory T cells from long-term Belatacept-treated kidney transplant patients restores their phenotype and suppressive function but not their FOXP3 TSDR demethylation status. Cell Immunol 2020;348:104044. [PMID: 32005344 DOI: 10.1016/j.cellimm.2020.104044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wallin EF. T Follicular Regulatory Cells and Antibody Responses in Transplantation. Transplantation 2018;102:1614-23. [PMID: 29757907 DOI: 10.1097/TP.0000000000002224] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kadono K, Dery KJ, Hirao H, Ito T, Kageyama S, Nakamura K, Oncel D, Aziz A, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW. Heme Oxygenase-1 dictates innate - adaptive immune phenotype in human liver transplantation. Arch Biochem Biophys 2019;671:162-6. [PMID: 31299184 DOI: 10.1016/j.abb.2019.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Castro-Rojas CM, Godarova A, Shi T, Hummel SA, Shields A, Tremblay S, Alloway RR, Jordan MB, Woodle ES, Hildeman DA. mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection. Transplantation 2020;104:1058-69. [PMID: 31415033 DOI: 10.1097/TP.0000000000002917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mortensen LA, Bistrup C, Thiesson HC. Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity? Front Med (Lausanne) 2017;4:210. [PMID: 29226122 DOI: 10.3389/fmed.2017.00210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Gupta G, Raynaud M, Kumar D, Sanghi P, Chang J, Kimball P, Kang L, Levy M, Sharma A, Bhati CS, Kamal L, Yakubu I, Massey HD, Kidd C, King AL, Halloran PF. Impact of belatacept conversion on kidney transplant function, histology, and gene expression - a single-center study. Transpl Int 2020;33:1458-71. [PMID: 32790889 DOI: 10.1111/tri.13718] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Saraf J, Bhattacharya P, Kalia K, Borah A, Sarmah D, Kaur H, Dave KR, Yavagal DR. A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders. ACS Cent Sci 2018;4:805-19. [PMID: 30062109 DOI: 10.1021/acscentsci.8b00230] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]